ADAMI, M., C. MICHELONI, D. GRANDI u. H. STARK (2018):
Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice.
Naunyn Schmiedebergs Arch Pharmacol 391, 1387-1397
AKDIS, C. A. u. F. E. SIMONS (2006):
Histamine receptors are hot in immunopharmacology.
Eur J Pharmacol 533, 69-76
ARNDT, J., N. SMITH u. F. TAUSK (2008):
Stress and atopic dermatitis.
Curr Allergy Asthma Rep 8, 312-317
BÄUMER, W., B. SULZLE, H. WEIGT, V. C. DE VRIES, M. HECHT, T. TSCHERNIG u. M. KIETZMANN (2005):
Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Br J Dermatol 153, 136-144
BÄUMER, W., S. WENDORFF, R. GUTZMER, T. WERFEL, D. DIJKSTRA, P.
CHAZOT, H. STARK u. M. KIETZMANN (2008):
Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine.
Allergy 63, 1387-1394
BÄUMER, W. u. K. ROSSBACH (2010):
Histamine as an immunomodulator.
J Dtsch Dermatol Ges 8, 495-504
82
BÄUMER, W., J. STAHL, K. SANDER, L. J. PETERSEN, J. PAPS, H. STARK, M.
KIETZMANN u. T. OLIVRY (2011):
Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis.
Exp Dermatol 20, 577-581
BAURECHT, H., M. C. RUHLEMANN, E. RODRIGUEZ, F. THIELKING, I. HARDER, A. S. ERKENS, D. STOLZL, E. ELLINGHAUS, M. HOTZE, W. LIEB, S. WANG, F. A.
HEINSEN-GROTH, A. FRANKE u. S. WEIDINGER (2018):
Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration.
J Allergy Clin Immunol 141, 1668-1676.e1616
BIEBER, T. (2008):
Atopic dermatitis.
N Engl J Med 358, 1483-1494
CORRIGAN, C. J., A. JAYARATNAM, Y. WANG, Y. LIU, R. DE WAAL MALEFYT, Q.
MENG, A. B. KAY, S. PHIPPS, T. H. LEE u. S. YING (2009):
Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.
Allergy 64, 1014-1022
COWDEN, J. M., M. ZHANG, P. J. DUNFORD u. R. L. THURMOND (2010):
The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation.
J Invest Dermatol 130, 1023-1033
EICHENSEER, M (2013):
Klinische Wirkung der Antihistaminika Chlorpheniramin/Hydroxyzin (Histaxalmine ®) und Dimetinden (Fenistil ®) bei atopischen Hunden.
München, Ludwig-Maximilians-Universität, Dissertation
EICHENSEER, M., C. JOHANSEN u. R. S. MUELLER (2013):
83
Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.
Vet Rec 173, 423
ROßBACH, K., H. KÖCHLING, T. FUKUYAMA, J. WILZOPOLSKI, M. KIETZMANN, W. BÄUMER:
Assessment of the Efficacy of Histamine Receptor Antagonists in Murine Models of Atopic Dermatitis.
in: EKATERNI, T., M. ENNIS (2017) (Hrsg):
Histamine receptors as drug targets.
Human Press, Springer Nature, New-York, S.233-262
FALLON, P. G., T. SASAKI, A. SANDILANDS, L. E. CAMPBELL, S. P. SAUNDERS, N. E. MANGAN, J. J. CALLANAN, H. KAWASAKI, A. SHIOHAMA, A. KUBO, J. P.
SUNDBERG, R. B. PRESLAND, P. FLECKMAN, N. SHIMIZU, J. KUDOH, A. D.
IRVINE, M. AMAGAI u. W. H. MCLEAN (2009):
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.
Nat Genet 41, 602-608
BOUCLIER, M., C.N. HENSBY, D. CAVEY:
Animal models used in cutaneous pharmacology
in: GALLI, C., C. N. HENSBY, M. MARINOVICH (1990) (Hrsg):
Skin Pharmacology and Toxicology.
Series A: Life Scienes Vol. 181, NATO ASI, Series, Plenum Press, New York, S.99-120
GEDON, N. K. Y. u. R. S. MUELLER (2018):
Atopic dermatitis in cats and dogs: a difficult disease for animals and owners.
Clin Transl Allergy 8, 41
GNIADECKI, R. (1996):
84
Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3:
dependence on cell culture conditions.
J Invest Dermatol 106, 510-516
GIROLOMONI, G. u. S. PASTORE (2001):
The role of keratinocytes in the pathogenesis of atopic dermatitis.
J Am Acad Dermatol 45, S25-28
GROBE, W., T. BIEBER u. N. NOVAK (2019):
Pathophysiologie der atopischen Dermatitis.
J Dtsch Dermatol Ges 17, 433-441
GUTERMUTH, J., M. OLLERT, J. RING, H. BEHRENDT u. T. JAKOB (2004):
Mouse models of atopic eczema critically evaluated.
Int Arch Allergy Immunol 135, 262-276
GUTZMER, R., C. DIESTEL, S. MOMMERT, B. KOTHER, H. STARK, M. WITTMANN u. T. WERFEL (2005):
Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.
J Immunol 174, 5224-5232
GUTZMER, R., M. GSCHWANDTNER, K. ROSSBACH, S. MOMMERT, T. WERFEL, M. KIETZMANN u. W. BAEUMER (2011):
Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus.
Front Biosci (Schol Ed) 3, 985-994
GUTZMER, R., S. MOMMERT, M. GSCHWANDTNER, K. ZWINGMANN, H. STARK u. T. WERFEL (2009):
The histamine H4 receptor is functionally expressed on T(H)2 cells.
J Allergy Clin Immunol 123, 619-625
HAMID, Q., M. BOGUNIEWICZ u. D. Y. LEUNG (1994):
85
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.
J Clin Invest 94, 870-876
HANIFIN, J. M., M. THURSTON, M. OMOTO, R. CHERILL, S. J. TOFTE u. M.
GRAEBER (2001):
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
Exp Dermatol 10, 11-18
HAY, R. J., N. E. JOHNS, H. C. WILLIAMS, I. W. BOLLIGER, R. P. DELLAVALLE, D.
J. MARGOLIS, R. MARKS, L. NALDI, M. A. WEINSTOCK, S. K. WULF, C. MICHAUD, J. L. M. C u. M. NAGHAVI (2014):
The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.
J Invest Dermatol 134, 1527-1534
HIKITA, I., T. YOSHIOKA, T. MIZOGUCHI, K. TSUKAHARA, K. TSURU, H. NAGAI, T. HIRASAWA, Y. TSURUTA, R. SUZUKI, M. ICHIHASHI u. T. HORIKAWA (2002):
Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: another possible model for atopic dermatitis.
J Dermatol Sci 30, 142-153
HILL, S. J. (1990):
Distribution, properties, and functional characteristics of three classes of histamine receptor.
Pharmacol Rev 42, 45-83
HILLIER, A. u. C. E. GRIFFIN (2001):
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
Vet Immunol Immunopathol 81, 147-151
HOFSTRA, C. L., P. J. DESAI, R. L. THURMOND u. W. P. FUNG-LEUNG b:
86
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.
J Pharmacol Exp Ther 305, 1212-1221
KAKE, T., M. IMAI u. N. TAKAHASHI
Effects of beta-carotene on oxazolone-induced atopic dermatitis in hairless mice.
Exp Dermatol 28, 1044-1050
KAMO, A., O. NEGI, S. TENGARA, Y. KAMATA, A. NOGUCHI, H. OGAWA, M.
TOMINAGA u. K. TAKAMORI (2014):
Histamine H(4) receptor antagonists ineffective against itch and skin inflammation in atopic dermatitis mouse model.
J Invest Dermatol 134, 546-548
KIM, B. S., M. C. SIRACUSA, S. A. SAENZ, M. NOTI, L. A. MONTICELLI, G. F.
SONNENBERG, M. R. HEPWORTH, A. S. VAN VOORHEES, M. R. COMEAU u. D.
ARTIS (2013):
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation.
Sci Transl Med 5, 170ra116
KLONOWSKA, J., J. GLEN, R. J. NOWICKI u. M. TRZECIAK (2018):
New Cytokines in the Pathogenesis of Atopic Dermatitis-New Therapeutic Targets.
Int J Mol Sci 19,
KÖCHLING, H., K. SCHAPER, J. WILZOPOLSKI, R. GUTZMER, T. WERFEL, W.
BÄUMER, M. KIETZMANN u. K. ROSSBACH (2017):
Combined treatment with H1 and H4 receptor antagonists reduces inflammation in a mouse model of atopic dermatitis.
J Dermatol Sci 87, 130-137
KÖCHLING, H (2015):
Etablierung des Ovalbumin-induzierten Mausmodells der atopischen Dermatitis zur Beurteilung pharmakologischer Wirkstoffe.
Hannover, Tierärztliche Hochschule, Dissertation
KOHARA, Y., K. TANABE, K. MATSUOKA, N. KANDA, H. MATSUDA, H.
KARASUYAMA u. H. YONEKAWA (2001):
87
A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on Chromosome 9.
Immunogenetics 53, 15-21
KOLLMEIER, A., K. FRANCKE, B. CHEN, P. J. DUNFORD, A. J. GREENSPAN, Y.
XIA, X. L. XU, B. ZHOU u. R. L. THURMOND (2014):
The histamine H(4) receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.
J Pharmacol Exp Ther 350, 181-187
LANDHEER, J., B. GIOVANNONE, S. SADEKOVA, S. TJABRINGA, C. HOFSTRA, K.
DECHERING, C. BRUIJNZEEL-KOOMEN, C. CHANG, Y. YING, R. DE WAAL MALEFYT, D. HIJNEN u. E. KNOL (2015):
TSLP is differentially regulated by vitamin D3 and cytokines in human skin.
Immun Inflamm Dis 3, 32-43
LEURS, R., M. J. SMIT u. H. TIMMERMAN (1995):
Molecular pharmacological aspects of histamine receptors.
Pharmacol Ther 66, 413-463
LI, M., P. HENER, Z. ZHANG, S. KATO, D. METZGER u. P. CHAMBON (2006):
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.
Proc Natl Acad Sci U S A 103, 11736-11741
LI, M., P. HENER, Z. ZHANG, K. P. GANTI, D. METZGER u. P. CHAMBON (2009):
Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin.
J Invest Dermatol 129, 498-502
LI, M., N. MESSADDEQ, M. TELETIN, J. L. PASQUALI, D. METZGER u. P.
CHAMBON (2005):
88
Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin.
Proc Natl Acad Sci U S A 102, 14795-14800
LIM, H. D., C. DE GRAAF, W. JIANG, P. SADEK, P. M. MCGOVERN, E. P.
ISTYASTONO, R. A. BAKKER, I. J. DE ESCH, R. L. THURMOND u. R. LEURS (2010):
Molecular determinants of ligand binding to H4R species variants.
Mol Pharmacol 77, 734-743
LIU, C., S. J. WILSON, C. KUEI u. T. W. LOVENBERG (2001):
Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.
J Pharmacol Exp Ther 299, 121-130
LIU, X. J., Z. L. MU, Y. ZHAO u. J. Z. ZHANG (2016):
Topical Tetracycline Improves MC903-induced Atopic Dermatitis in Mice through Inhibition of Inflammatory Cytokines and Thymic Stromal Lymphopoietin Expression.
Chin Med J (Engl) 129, 1483-1490
MATSUDA, H., N. WATANABE, G. P. GEBA, J. SPERL, M. TSUDZUKI, J. HIROI, M.
MATSUMOTO, H. USHIO, S. SAITO, P. W. ASKENASE u. C. RA (1997):
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice.
Int Immunol 9, 461-466
MATSUOKA, H., N. MAKI, S. YOSHIDA, M. ARAI, J. WANG, Y. OIKAWA, T. IKEDA, N. HIROTA, H. NAKAGAWA u. A. ISHII (2003):
A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae.
Allergy 58, 139-145
MATSUSHITA, A., M. SEIKE, H. OKAWA, Y. KADAWAKI u. H. OHTSU (2012):
89
Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis.
Exp Dermatol 21, 714-715
MICHELS, G. M., K. F. WALSH, K. A. KRYDA, S. P. MAHABIR, R. R. WALTERS, J.
D. HOEVERS u. O. M. MARTINON (2016):
A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
Vet Dermatol 27, 505-e136
MOISSON, L (2018):
Untersuchung im Mausmodell des Ovalbumin induzierten Entzündungsgeschehens als Modell der atopischen Dermatitis.
Hannover, Tierärztliche Hochschule, Dissertation
MOMMERT, S., M. GSCHWANDTNER, R. GUTZMER u. T. WERFEL (2011):
The role of the histamine H4 receptor in atopic dermatitis.
Curr Allergy Asthma Rep 11, 21-28
MOOSBRUGGER-MARTINZ, V., M. SCHMUTH u. S. DUBRAC (2017):
A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903.
Methods Mol Biol 1559, 91-106
MOSSNER, J. u. K. CACA (2005):
Developments in the inhibition of gastric acid secretion.
Eur J Clin Invest 35, 469-475
MU, Z., Y. ZHAO, X. LIU, C. CHANG u. J. ZHANG (2014):
Molecular biology of atopic dermatitis.
Clin Rev Allergy Immunol 47, 193-218
90
MURATA, Y., M. SONG, H. KIKUCHI, K. HISAMICHI, X. L. XU, A. GREENSPAN, M.
KATO, C. F. CHIOU, T. KATO, C. GUZZO, R. L. THURMOND, M. OHTSUKI u. M.
FURUE (2015):
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
J Dermatol 42, 129-139
NAIDOO, K., F. JAGOT, L. VAN DEN ELSEN, C. PELLEFIGUES, A. JONES, H. LUO, K. JOHNSTON, G. PAINTER, B. ROEDIGER, J. LEE, W. WENINGER, G. LE GROS u. E. FORBES-BLOM (2018):
Eosinophils Determine Dermal Thickening and Water Loss in an MC903 Model of Atopic Dermatitis.
J Invest Dermatol 138, 2606-2616
NAKAMURA, T., H. ITADANI, Y. HIDAKA, M. OHTA u. K. TANAKA (2000):
Molecular cloning and characterization of a new human histamine receptor, HH4R.
Biochem Biophys Res Commun 279, 615-620
NICHOLSON, A. N., P. A. PASCOE, C. TURNER, C. R. GANELLIN, P. M.
GREENGRASS, A. F. CASY u. A. D. MERCER (1991):
Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.
Br J Pharmacol 104, 270-276
NUTTEN, S. (2015):
Atopic dermatitis: global epidemiology and risk factors.
Ann Nutr Metab 66 Suppl 1, 8-16
O'REILLY, M., R. ALPERT, S. JENKINSON, R. P. GLADUE, S. FOO, S. TRIM, B.
PETER, M. TREVETHICK u. M. FIDOCK (2002):
Identification of a histamine H4 receptor on human eosinophils--role in eosinophil chemotaxis.
J Recept Signal Transduct Res 22, 431-448
91
ODA, T., N. MORIKAWA, Y. SAITO, Y. MASUHO u. S. MATSUMOTO (2000):
Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.
J Biol Chem 275, 36781-36786
OLIVRY, T., D. J. DEBOER, C. FAVROT, H. A. JACKSON, R. S. MUELLER, T.
NUTTALL u. P. PRELAUD (2010):
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Vet Dermatol 21, 233-248
OLIVRY, T., D. J. DEBOER, C. FAVROT, H. A. JACKSON, R. S. MUELLER, T.
NUTTALL u. P. PRELAUD (2015):
Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).
BMC Vet Res 11, 210
OLIVRY, T. u. P. B. HILL (2001):
The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions.
Vet Immunol Immunopathol 81, 305-309
PANULA, P., P. L. CHAZOT, M. COWART, R. GUTZMER, R. LEURS, W. L. LIU, H.
STARK, R. L. THURMOND u. H. L. HAAS (2015):
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Pharmacol Rev 67, 601-655
PASTORE, S., E. FANALES-BELASIO, C. ALBANESI, L. M. CHINNI, A. GIANNETTI u. G. GIROLOMONI (1997):
Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.
J Clin Invest 99, 3009-3017
92
ROSSBACH, K., C. NASSENSTEIN, M. GSCHWANDTNER, D. SCHNELL, K.
SANDER, R. SEIFERT, H. STARK, M. KIETZMANN u. W. BÄUMER (2011):
Histamine H1, H3 and H4 receptors are involved in pruritus.
Neuroscience 190, 89-102
ROSSBACH, K., K. SCHAPER, C. KLOTH, R. GUTZMER, T. WERFEL, M.
KIETZMANN u. W. BÄUMER (2016):
Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis.
Allergy 71, 189-197
ROSSBACH, K., S. WENDORFF, K. SANDER, H. STARK, R. GUTZMER, T.
WERFEL, M. KIETZMANN u. W. BÄUMER (2009):
Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation.
Exp Dermatol 18, 57-63
ROTHMEIER, A. S. u. W. RUF (2012):
Protease-activated receptor 2 signaling in inflammation.
Semin Immunopathol 34, 133-149
SANDER, K., T. KOTTKE u. H. STARK (2008):
Histamine H3 receptor antagonists go to clinics.
Biol Pharm Bull 31, 2163-2181
SANTORO, D., R. MARSELLA, C. M. PUCHEU-HASTON, M. N. EISENSCHENK, T.
NUTTALL u. P. BIZIKOVA (2015):
Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.
Vet Dermatol 26, 84-e25
93
SAVALL, B. M., F. CHAVEZ, K. TAYS, P. J. DUNFORD, J. M. COWDEN, M. D. HACK, R. L. WOLIN, R. L. THURMOND u. J. P. EDWARDS (2014):
Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H(4) receptor antagonists.
J Med Chem 57, 2429-2439
SCHAPER-GERHARDT, K., K. ROSSBACH, E. NIKOLOULI, T. WERFEL, R.
GUTZMER u. S. MOMMERT (2018):
The role of the histamine H4 receptor in atopic dermatitis and psoriasis.
Br J Pharmacol
SCHAPER, K., K. ROSSBACH, B. KOTHER, H. STARK, M. KIETZMANN, T. WERFEL u. R. GUTZMER (2016):
Stimulation of the histamine 4 receptor upregulates thymic stromal lymphopoietin (TSLP) in human and murine keratinocytes.
Pharmacol Res 113, 209-215
SCHEINMAN, R. I., A. GUALBERTO, C. M. JEWELL, J. A. CIDLOWSKI u. A. S.
BALDWIN, JR. (1995):
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Mol Cell Biol 15, 943-953
SCHMITT, J., N. M. SCHMITT, W. KIRCH u. M. MEURER (2009):
Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony.
Histamine and H1-antihistamines: celebrating a century of progress.
J Allergy Clin Immunol 128, 1139-1150.e1134
94
SOUMELIS, V., P. A. RECHE, H. KANZLER, W. YUAN, G. EDWARD, B. HOMEY, M.
GILLIET, S. HO, S. ANTONENKO, A. LAUERMA, K. SMITH, D. GORMAN, S.
ZURAWSKI, J. ABRAMS, S. MENON, T. MCCLANAHAN, R. DE WAAL-MALEFYT RD, F. BAZAN, R. A. KASTELEIN u. Y. J. LIU (2002):
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
Nat Immunol 3, 673-680
SPERGEL, J. M., E. MIZOGUCHI, J. P. BREWER, T. R. MARTIN, A. K. BHAN u. R.
S. GEHA (1998):
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.
J Clin Invest 101, 1614-1622
SPRAGGON, G., M. HORNSBY, A. SHIPWAY, D. C. TULLY, B. BURSULAYA, H.
DANAHAY, J. L. HARRIS u. S. A. LESLEY (2009):
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations.
Protein Sci 18, 1081-1094
SUGATA, Y., M. OKANO, T. FUJIWARA, R. MATSUMOTO, H. HATTORI, M.
YAMAMOTO, M. NISHIBORI u. K. NISHIZAKI (2007):
Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses.
Immunology 121, 266-275
SUWA, E., K. YAMAURA, M. ODA, T. NAMIKI u. K. UENO (2011):
Histamine H(4) receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model.
Eur J Pharmacol 667, 383-388
THURMOND, R. L. (2015):
The histamine H4 receptor: from orphan to the clinic.
Front Pharmacol 6, 65
95
THURMOND, R. L., P. J. DESAI, P. J. DUNFORD, W. P. FUNG-LEUNG, C. L.
HOFSTRA, W. JIANG, S. NGUYEN, J. P. RILEY, S. SUN, K. N. WILLIAMS, J. P.
EDWARDS u. L. KARLSSON (2004):
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties.
J Pharmacol Exp Ther 309, 404-413
THURMOND, R. L., E. W. GELFAND u. P. J. DUNFORD (2008):
The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines.
Nat Rev Drug Discov 7, 41-53
THURMOND, R. L., B. CHEN, P. J. DUNFORD, A. J. GREENSPAN, L. KARLSSON, D. LA, P. WARD u. X. L. XU (2014):
Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.
J Pharmacol Exp Ther 349, 176-184
WEICHHART, T., O. BRANDT, C. LASSNIG, M. MULLER, W. H. HORL, G. STINGL u. M. D. SAEMANN (2010):
The anti-inflammatory potency of dexamethasone is determined by the route of application in vivo.
Immunol Lett 129, 50-52
WERFEL, T. (2009):
The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis.
J Invest Dermatol 129, 1878-1891
WERFEL, T., W. ABERER, F. AHRENS, M. AUGUSTIN, T. BIEDERMANN, T.
DIEPGEN, R. FOLSTER-HOLST, U. GIELER, A. HERATIZADEH, J. KAHLE, A.
KAPP, A. NAST, K. NEMAT, H. OTT, B. PRZYBILLA, M. ROECKEN, M.
SCHLAEGER, P. SCHMID-GRENDELMEIER, J. SCHMITT, T. SCHWENNESEN, D.
STAAB u. M. WORM (2016a):
Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]
J Dtsch Dermatol Ges 14, e1-75
96
WERFEL, T., J. P. ALLAM, T. BIEDERMANN, K. EYERICH, S. GILLES, E.
GUTTMAN-YASSKY, W. HOETZENECKER, E. KNOL, H. U. SIMON, A.
WOLLENBERG, T. BIEBER, R. LAUENER, P. SCHMID-GRENDELMEIER, C.
TRAIDL-HOFFMANN u. C. A. AKDIS (2016a):
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
J Allergy Clin Immunol 138, 336-349
WERFEL, T., A. HERATIZADEH, W. ABERER, F. AHRENS, M. AUGUSTIN, T.
BIEDERMANN, T. DIEPGEN, R. FOLSTER-HOLST, U. GIELER, J. KAHLE, A. KAPP, A. NAST, K. NEMAT, H. OTT, B. PRZYBILLA, M. ROECKEN, M. SCHLAEGER, P.
SCHMID-GRENDELMEIER, J. SCHMITT, T. SCHWENNESEN, D. STAAB u. M.
WORM (2016b):
S2k guideline on diagnosis and treatment of atopic dermatitis--short version.
J Dtsch Dermatol Ges 14, 92-106
WERFEL, T., G. LAYTON, M. YEADON, L. WHITLOCK, I. OSTERLOH, P. JIMENEZ, W. LIU, V. LYNCH, A. ASHER, A. TSIANAKAS u. L. PURKINS (2019):
Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis.
J Allergy Clin Immunol 143, 1830-1837.e1834
YASUDA, T., T. FUKADA, K. NISHIDA, M. NAKAYAMA, M. MATSUDA, I. MIURA, T.
DAINICHI, S. FUKUDA, K. KABASHIMA, S. NAKAOKA, B. H. BIN, M. KUBO, H.
OHNO, T. HASEGAWA, O. OHARA, H. KOSEKI, S. WAKANA u. H. YOSHIDA (2016):
Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis.
J Clin Invest 126, 2064-2076
ZHANG, Z., P. HENER, N. FROSSARD, S. KATO, D. METZGER, M. LI u. P.
CHAMBON (2009):
Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma.
Proc Natl Acad Sci U S A 106, 1536-1541
97 ZIEGLER, S. F. (2012):
Thymic stromal lymphopoietin and allergic disease.
J Allergy Clin Immunol 130, 845-852
ZIEGLER, S. F. u. Y. J. LIU (2006):
Thymic stromal lymphopoietin in normal and pathogenic T cell development and function.
Nat Immunol 7, 709-714
ZIMMERMANN, A. S., H. BURHENNE, V. KAEVER, R. SEIFERT u. D. NEUMANN (2011):
Systematic analysis of histamine and N-methylhistamine concentrations in organs from two common laboratory mouse strains: C57Bl/6 and Balb/c.
Inflamm Res 60, 1153-1159
98